Aptecar et al. recently found that PTPN13 downregulation in ovarian cancer was linked to resistance to platinum and taxane therapy and EMT, as indicated by Snail, Slug, Zeb1, and Zeb2 expression [86]. This evidence concerns the gene SNAI1 and ovarian carcinoma.